secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptive Biotechnologies Corp (ADPT)
CIK:        0001478320
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001193125-23-181293
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adaptive Biotechnologies receives Nasdaq notice for Audit Committee non-compliance after director resignation
--------------------------------------------------------------------------------

- On June 13, 2023, board member Leslie Trigg resigned, reducing Audit Committee to two members.
- Nasdaq rule 5605(c)(2)(A) requires at least three members on Audit Committee.
- Company received non-compliance notice on June 26, 2023, with a cure period to regain compliance.
- Company is evaluating board committee composition and intends to cure within the applicable period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478320/000119312523181293/0001193125-23-181293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478320/000119312523181293/d530995d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-181293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer